SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SD - Specialized disclosure report:
SEC Accession No. 0001437749-23-016311
Filing Date
2023-06-01
Accepted
2023-05-31 19:24:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 FORM SD navb20230531_sd.htm SD 15089
  Complete submission text file 0001437749-23-016311.txt   16263
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SD | Act: 34 | File No.: 001-35076 | Film No.: 23982640
SIC: 2835 In Vitro & In Vivo Diagnostic Substances